GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (NYSE:WAT) » Definitions » Cyclically Adjusted Price-to-FCF

Waters (Waters) Cyclically Adjusted Price-to-FCF : 36.85 (As of Apr. 30, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Waters Cyclically Adjusted Price-to-FCF?

As of today (2024-04-30), Waters's current share price is $313.555. Waters's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $8.51. Waters's Cyclically Adjusted Price-to-FCF for today is 36.85.

The historical rank and industry rank for Waters's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

WAT' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 25.93   Med: 35.46   Max: 60.57
Current: 37.03

During the past years, Waters's highest Cyclically Adjusted Price-to-FCF was 60.57. The lowest was 25.93. And the median was 35.46.

WAT's Cyclically Adjusted Price-to-FCF is ranked worse than
55.56% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 34.35 vs WAT: 37.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Waters's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $3.180. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $8.51 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Waters Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Waters's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Cyclically Adjusted Price-to-FCF Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.47 38.10 50.66 42.57 38.69

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.57 37.24 32.36 32.64 38.69

Competitive Comparison of Waters's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Waters's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Waters's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Waters's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Waters's Cyclically Adjusted Price-to-FCF falls into.



Waters Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Waters's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=313.555/8.51
=36.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Waters's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Waters's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3.18/129.4194*129.4194
=3.180

Current CPI (Dec. 2023) = 129.4194.

Waters Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 1.099 99.695 1.427
201406 0.981 100.560 1.263
201409 1.182 100.428 1.523
201412 1.500 99.070 1.960
201503 1.590 99.621 2.066
201506 1.069 100.684 1.374
201509 1.355 100.392 1.747
201512 1.648 99.792 2.137
201603 1.669 100.470 2.150
201606 1.644 101.688 2.092
201609 1.548 101.861 1.967
201612 1.868 101.863 2.373
201703 1.938 102.862 2.438
201706 1.912 103.349 2.394
201709 1.668 104.136 2.073
201712 2.014 104.011 2.506
201803 2.005 105.290 2.464
201806 1.018 106.317 1.239
201809 1.134 106.507 1.378
201812 2.406 105.998 2.938
201903 2.073 107.251 2.501
201906 1.259 108.070 1.508
201909 1.548 108.329 1.849
201912 2.158 108.420 2.576
202003 1.605 108.902 1.907
202006 2.459 108.767 2.926
202009 2.316 109.815 2.729
202012 3.525 109.897 4.151
202103 2.856 111.754 3.307
202106 1.587 114.631 1.792
202109 2.071 115.734 2.316
202112 2.823 117.630 3.106
202203 2.712 121.301 2.894
202206 0.164 125.017 0.170
202209 1.938 125.227 2.003
202212 2.285 125.222 2.362
202303 2.737 127.348 2.782
202306 -0.483 128.729 -0.486
202309 2.021 129.860 2.014
202312 3.180 129.419 3.180

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Waters  (NYSE:WAT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Waters Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Waters's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (Waters) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.
Executives
Christopher A Kuebler director 210 CARNEGIE CENTER, PRINCETON NJ 08540
Richard H Fearon director 1239 GERBING ROAD, AMELIA ISLAND FL 32034
Edward Conard director
Daniel J. Brennan director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Mark P Vergnano director 1007 MARKET STREET, WILMINGTON DE 19898
Gary E Hendrickson director 1101 THIRD STREET SOUTH, MINNEAPOLIS MN 55415
John M Ballbach director
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Michael J Berendt director
Thomas P Salice director
Wei Jiang director 34 MAPLE STREET, MILFORD MA 01757
Amol Chaubal officer: SVP and Chief Financial Office 113 HARTWELL AVE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421
Jianqing Bennett officer: SVP TA Instruments Division 34 MAPLE STREET, MILFORD MA 01757
Joann A Reed director C/O AMERICAN TOWER CORP, 116 HUNTINGTON AVENUE, BOSTON MA 02116
Belinda Hyde officer: SVP, Global Human Resources 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277

Waters (Waters) Headlines

From GuruFocus

Q4 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2021 Waters Corp Earnings Call Transcript

By GuruFocus Research 01-23-2024

Waters Corp Investor Day Transcript

By GuruFocus Research 01-23-2024